Megan Smeykal
Known title: Chief Accounting OfficerCIK: 0001899973
Associated companies
Transaction History
| TELA | ▼ Sell | Tax Withholding | 423 | $324 | 2/23/2026 | View on chart |
| TELA | ▼ Sell | Tax Withholding | 1,590 | $1K | 2/21/2026 | View on chart |
| TELA | ▼ Sell | Tax Withholding | 795 | $632 | 2/19/2026 | View on chart |
| TELA | ▲ Buy | Grant | 32,850 | $0 | 2/18/2026 | View on chart |
| TELA | ▼ Sell | Tax Withholding | 96 | $117 | 3/31/2025 | View on chart |
| TELA | ▼ Sell | Tax Withholding | 539 | $1K | 2/24/2025 | View on chart |
| TELA | ▼ Sell | Tax Withholding | 423 | $1K | 2/23/2025 | View on chart |
| TELA | ▼ Sell | Tax Withholding | 1,590 | $4K | 2/21/2025 | View on chart |
| TELA | ▲ Buy | Grant | 9,400 | $0 | 2/19/2025 | View on chart |
| TELA | ▼ Sell | Tax Withholding | 96 | $544 | 3/31/2024 | View on chart |
| TELA | ▼ Sell | Tax Withholding | 539 | $4K | 2/24/2024 | View on chart |
| TELA | ▼ Sell | Tax Withholding | 423 | $3K | 2/23/2024 | View on chart |
| TELA | ▲ Buy | Grant | 9,400 | $0 | 2/21/2024 | View on chart |
| TELA | ▼ Sell | Tax Withholding | 795 | $6K | 2/21/2024 | View on chart |
| TELA | ▼ Sell | Tax Withholding | 96 | $1K | 3/31/2023 | View on chart |
| TELA | ▼ Sell | Tax Withholding | 539 | $6K | 2/24/2023 | View on chart |
| TELA | ▼ Sell | Tax Withholding | 423 | $4K | 2/23/2023 | View on chart |
| TELA | ▲ Buy | Grant | 9,400 | $0 | 2/21/2023 | View on chart |
| TELA | ▼ Sell | Tax Withholding | 93 | $1K | 3/31/2022 | View on chart |
| TELA | ▼ Sell | Tax Withholding | 535 | $6K | 2/24/2022 | View on chart |
| TELA | ▲ Buy | Grant | 5,000 | $0 | 2/23/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Craig-Hallum initiates coverage on TELA Bio with $2 target
Craig-Hallum has started tracking TELA Bio, assigning a price target of $2. This new analyst note aligns with the current average analyst target of $2.08. The stock is currently trading above its 52-week low of $0.50, with recent technical indicators showing momentum near the upper end of its recent range.
Craig-Hallum initiates coverage on TELA Bio with $2 target. Craig-Hallum has started tracking TELA Bio, assigning a price target of $2. This new analyst note aligns with the current average analyst target of $2.08. The stock is currently trading above its 52-week low of $0.50, with recent technical indicators showing momentum near the upper end of its recent range.